Comment from OUTSOURCING FACILITIES ASSOCIATION
AnonymousSupportAdvocacy
Summary: OFA (an advocacy organization) supports the inclusion of Nicotinamide Riboside Chloride on the 503B Bulks List as a Category 1 substance. They argue that this listing is necessary for developers to partner with outsourcing facilities to compound the substance for human clinical trials and are committed to providing the FDA with ongoing safety and efficacy data.
See attached file(s)